Global Metagenomic Sequencing Market Will Grow At Highest Pace Owing To Increasing Applications In Clinical Diagnostics
Metagenomic sequencing involves direct extraction and sequencing of DNA from environmental samples containing microbial communities without culturing the individual species. It allows microbial identification and characterization directly from any habitat.
The Global Metagenomic Sequencing Market Size Is Estimated To Be Valued At US$ 1.41 Bn In 2024 And Is Expected To Exhibit A CAGR Of 17% Over The Forecast Period 2024-2031.
Metagenomic sequencing is gaining popularity as it allows studying the microbial composition in various environments like soil, oceans and human microbiome without isolating individual species. It has enabled identification of novel microbes and enhanced understanding of complex microbial communities. Metagenomics finds diverse applications such as human gut microbiome analysis, improving agricultural yields by optimizing plant microbiomes, biodiversity assessment and bioprospecting. With advancements in NGS technologies, metagenomic sequencing is increasingly being used in clinical diagnostics to identify pathogens, detect antibiotic resistance genes and understand role of microbiome in various diseases.
Key Takeaways
Key players operating in the Global Metagenomic Sequencing Market are Illumina, Qiagen, Thermo Fisher Scientific, Oxford Nanopore Technologies, Bgi Group, Perkinelmer, Genewiz, Macrogen, Zymo Research, Diversigen, Microsynth Ag, Baseclear, Mr Dna (Molecular Research), Eurofins Scientific, Novogene Corporation, Nugen Technologies, Takara Bio, Swift Biosciences, New England Biolabs, And Cosmosid.
The metagenomic sequencing market is driven by growing applications in clinical research for analyzing human microbiome and its associations with various chronic diseases like diabetes, obesity, cancer etc. Identification of novel microbial species and characterization of microbial communities through metagenomics is also fueling market growth.
Advances in next-generation sequencing technologies have improved throughput, reduced costs and enabled application of metagenomics at large scale. Developments in long-read sequencing, nanopore sequencing, portable sequencing devices are further expanding scope of metagenomic applications.
Market Trends
Single cell metagenomics is emerging as a key trend, allowing characterization of individual microbial species within complex communities. It provides high resolution analysis of uncultured microbes.
Metatranscriptomics which involves sequencing mRNA is gaining traction for understanding active functions and pathways of microbial communities in specific environments. Combined approaches like metaproteomics and metabolomics are also being explored.
Market Opportunities
Increased focus on gut microbiome-based therapeutics and diagnostics for various metabolic, immune and neurological disorders presents significant opportunities.
Growing ITS applications in agriculture sector for enriching soil microbiomes, optimizing plant growth, mitigating effects of climate change through metagenomics also offers scope for market expansion.
Impact Of COVID-19 On Global Metagenomic Sequencing Market Growth
The COVID-19 pandemic has significantly impacted the growth of the global metagenomic sequencing market. During the initial phase of the pandemic in 2020, the market experienced a decline in growth owing to lockdown restrictions imposed across various countries. This led to delays in research activities, disruptions in supply chains and reduced lab operations for R&D purposes. However, as the pandemic progressed, metagenomic sequencing emerged as a powerful tool to study the novel coronavirus and its impact on human microbiomes. Several research studies analyzed the composition of pathogenic and beneficial microbes in COVID-19 patients using metagenomic approaches. This boosted the demand for sequencing supplies, kits and services during the pandemic. In the post-COVID era, the market is expected to witness accelerated growth. Life sciences companies are investing heavily in pandemic preparedness and infectious disease research. Growing focus on microbiome therapeutics and clinical applications of metagenomics will further support the industry expansion over the forecast period.
In terms of regional distribution of value, North America accounted for the largest share of the global metagenomic sequencing market in 2024. This is attributed to extensive R&D activities undertaken in the healthcare and genomic sectors across the US and Canada. The regional market was further driven by increasing private sector funding for metagenomics startups and growing collaborations between academic institutions and life sciences vendors. Asia Pacific exhibited the fastest growth rate during the historical period due to rising healthcare expenditure, favorable government policies and expanding metagenomics capabilities of China and India. The Asia Pacific market is anticipated to continue outpacing other regional markets through 2031, supported by rapid economic development, growing genomic initiatives and burgeoning biotech industries in various countries.
What are the key data covered in this Global Metagenomic Sequencing Market report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Global Metagenomic Sequencing Market's growth between 2024 and 2031.
:- Accurate calculation of the size of the Global Metagenomic Sequencing Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behavior
:- Global Metagenomic Sequencing Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Global Metagenomic Sequencing Market vendors
FAQ’s
Q.1 What are the main factors influencing the Global Metagenomic Sequencing market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Metagenomic Sequencing Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Metagenomic Sequencing market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
Get more insights on this topic: https://www.ukwebwire.com/global-metagenomic-sequencing-market-trend-size-and-demand/
Comments
0 comment